Victor Lin, MD
Hematology & Oncology · Baton Rouge, LANPI 1568806818
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $7,258 of the $10,295 with a category attached, or 70.5%. It is spread thinly across 60 manufacturers, the largest accounting for just 16.5%. 2025 is the largest year on record at $3,085, 3.7 times the $826 reported in 2019.
Across 300 payments — averaging $34.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$2K
- Bayer$955
- AstraZeneca$907
- Roche Molecular Systems, Inc.$666
- Daiichi Sankyo Inc.$385
- E.r. Squibb & Sons, L.L.C.$325
- plus $5K from 54 others
Across 169 payments — averaging $13,606 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$956K
- Eli Lilly$236K
- Merck$234K
- AstraZeneca$190K
- AVEO Pharmaceuticals, Inc.$178K
- Genentech, Inc.$136K
- plus $369K from 11 others
What the payments were for
- Consulting fees$9009%
- Speaking & faculty fees$4004%
- Travel & lodging$1,49715%
- Food & beverage$7,25871%
- Education$2402%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LENVIMA$1,497
- Vitrakvi$900
- DIAGNOSTICS INFORMATION SYSTEMS$666
- Varian Treatment$197
- OSTEOCOOL RF ABLATION SYSTEM$150
- PEMFEXY$149
- FRUZAQLA$122
- BRUKINSA$109
How this compares
$10,295 in reported general payments places this provider in the 65th percentile of 183 hematology & oncology providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other hematology & oncology in Baton Rouge
- Hana SafahBaton Rouge$2M
- Nakhle SabaBaton Rouge$842K
- Sanjay JunejaBaton Rouge$346K
- Andrew DalovisioBaton Rouge$128K
- Greg BizetteBaton Rouge$32K
- Marshall StaggBaton Rouge$19K
- Christopher McCanlessBaton Rouge$18K
- Georgios ConstantinouBaton Rouge$15K
- Lauren JunejaBaton Rouge$14K
- Pedro BarataNew Orleans$928K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.